bioRxiv · 18 Nov 2026
Combined nelfinavir and cisplatin treatment promotes inflammatory signaling and immunogenic cell death in ovarian cancer cells
Benjamin Forgieh-index 1, Sarah Ferrier, Alicia A Goyeneche, Alexandra Bartolomucci, Desiree Marmo, Rewati Prakash, Abu SM Noman, Edith Zorychta, Lucy Gilbert, Julia V Burnier, Carlos M Telleriah-index 12
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Platinum (Pt) based chemotherapy remains central to ovarian cancer (OC) treatment, but recurrent disease frequently develops Pt resistance and responds poorly to immune checkpoint inhibitors. Immunogenic cell death (ICD) links tumor cell killing to antitumor immunity; however, cisplatin (CDDP), widely used in OC, is an incomplete ICD inducer. We previously demonstrated that the HIV protease inhibitor nelfinavir (NFV) enhances CDDP induced OC cell death and promotes a lytic, pyroptosis associated phenotype. Here, we investigated whether NFV enhances the immunogenic consequences of CDDP treatment. RNA seq analysis of OC cells treated with CDDP, NFV, or their combination revealed enrichment of interferon (IFN) associated, cytoplasmic DNA sensing, inflammatory chemokine, and antigen presentation pathways following NFV containing treatments. NFV alone and CDDP plus NFV reduced mature Lamin A abundance and increased extranuclear double stranded DNA accumulation. Cytosolic fractionation and droplet digital PCR demonstrated increased cytosolic TP53 DNA, particularly following combined treatment. CDDP plus NFV increased STING and TBK1 phosphorylation, supporting engagement of the cGAS STING TBK1 signaling pathway. The combination enhanced release of inflammatory and ICD associated mediators, including HMGB1, IL18, and IFNbeta. Importantly, vaccination with CDDP plus NFV-treated murine ID8 OC cells protected immunocompetent female mice against subsequent live ID8 cell challenge, reducing tumor incidence and burden. In contrast, ID8 cells killed by freeze thaw-induced accidental necrosis provided no comparable protection. Collectively, these findings indicate that NFV enhances the immunogenic consequences of CDDP induced OC cell death, potentially involving cytoplasmic DNA accumulation and STING TBK1 signaling, and promotes protective antitumor immunity in vivo. These results support further investigation of NFV as a repurposed partner for Pt based chemotherapy and its potential combination with immunotherapy in OC.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Carlos M Telleria has the highest h-index among the authors (12).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.